Viewing Study NCT02115204


Ignite Creation Date: 2025-12-24 @ 8:03 PM
Ignite Modification Date: 2026-01-07 @ 5:37 AM
Study NCT ID: NCT02115204
Status: COMPLETED
Last Update Posted: 2019-10-03
First Post: 2014-04-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: 4 x Epirubicin, Cyclophosphamide, Followed by 4 x Docetaxel Versus 6 x CMF / 6 x CEF
Sponsor: West German Study Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module